BCL10 and neoplasm: The abnormalities of MYD88, mucosa associated lymphoid tissue lymphoma translocation gene 1 (MALT1), B-cell lymphoma 10 (BCL10), and other functional driver genes may lead to the excitation of the NF-κB signaling pathway in DLBCL, promoting proliferation of tumor cells, and ultimately leading to tumorgenesis of DLBCL [50].